RUNX1 was found to be commonly mutated during both CML-CP diagnosis and blast phase, often in cooccurrence with other recurrent mutations (17, 18). This evidence concerns the gene RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive.